Leading scientists from across the world will take part in a jointEFSA/EBTC scientificcolloquium: “ Evidence integration in risk assessment: the science of combining apples and oranges". The colloquium takes place in Lisbon, Portugal on 25-26 October. It is the 23rd in the EFSA scientific colloquium series and is jointly organized with EBTC at Johns Hopkins Bloomberg School of Public Health.Registration will open in late May so be sure to save the date.
EBTC is hiring a Post-Doctorial Researcher. Click here for more information or to apply now!
EBTC’s Katya Tsaioun has been awarded a $50,000 prize from the Beagle Freedom Project. Full details here!
EBTC presented at the Society of Toxicology annual meeting in Baltimore: EBTC Director Katya Tsaioun gave an update on the Evidence-based Toxicology Collaboration at the SOT satellite meeting "Updates on Activities Related to 21st Century Toxicology and Related Efforts: Invited Presentations and Open Microphone" on Thursday, March 16th at The Lord Baltimore Hotel in the Baltimore Theater from 12:30-4pm.
Monday March 14, 2016, 9:30 AM to 12:15 PM Martin Stephens presented in the Workshop Session: "Scientific Reproducibility: Does This Pose a Problem for 21st Century Toxicology?" Marty presented on Evidence-Based Approaches for Enhancing the Reproducibility of Toxicological Studies.
Wednesday, March 16, 2016, 9:30 AM to 12:15 PM Poster presentation (#2632, P130): A Systematic Review of the Zebrafish Embryological Test as an Alternative to the Mammalian Developmental Test (OECD 414): A Pilot for an Evidence-Based Toxicology Approach.
Wednesday, March 16, 2016 The Director of EBTC, Katya Tsaioun co-chaired a workshop entitled: Paradigm Change in Toxicology: What Will It Take to Bring Advances in the Science of Toxicology into Regulatory Use? The workshop aimed at defining a path towards systematic assessment of the criteria for inclusion of new science into regulatory decisions for different industries and included representatives from pharmaceutical, cosmetic and agrochemical industries and regulators from US FDA and EChA. The workshop presenters included presentations from Derek Knight (European Chemicals Agency (EChA)), Abigail Jacobs (US FDA), Marco Corvaro (Dow Agrochemicals), Gladys Ouedraogo (L’Oréal) and Yvonne Will (Pfizer). The workshop concluded with a presentation on the importance of evidence-based methods in advancing regulatory science by Ellen Silbergeld from Johns Hopkins Bloomberg School of Public Health and Daniel Mandrioli from Ramazzini Institute.
Thursday, March 17, 12:30 PM to 4:00 PM Satellite Meeting on 21st Century Toxicology chaired by Professor Thomas Hartung: Updates on Activities Related to 21st Century Toxicology and Related Efforts: Invited Presentations and Open Microphone. Martin Stephens gave an update on the EBTC.
February 8 – 10, 2016 The EBTC Director Katya Tsaioun presented at the ToxForum Annual Winter Meeting in Washington, DC. The talk title: Translation of Diagnostic Test Accuracy Guidelines to Toxicology Test Method Performance: Zebrafish Embryo Test as a Predictor of Developmental Toxicity.
December 16 - 17, 2015 The EBTC’s Alexandra Maertens presented lessons learned from its zebrafish embryotoxicity study at the US EPA Advancing Systematic Review Workshop held in Arlington, VA. The purpose of the workshop was to examine developments and applications of methods for the identification and evaluation of different types of evidence (epidemiology, animal toxicology, and mechanistic) for use in chemical assessments.
Johns Hopkins Bloomberg School of Public Health 615 N. Wolfe Street, Baltimore, MD 21205